Vaxcyte (PCVX) Share-based Compensation (2019 - 2026)
Vaxcyte's Share-based Compensation was $41.24 million in Q2 2026, up 11.7% from $36.93 million a year earlier and up 8.6% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Share-based Compensation (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vaxcyte's Share-based Compensation was $150.51 million through Jun 30, 2026, up 33.0% year-over-year; for FY2025, it was $138.85 million, up 63.7% from FY2024.
- Share-based Compensation has now increased for seven consecutive years, with a five-year compound annual growth rate of 91.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $84.82 million in FY2024 (+74.0%), $48.76 million in FY2023 (+106.2%), $23.65 million in FY2022 (+120.4%) and $10.73 million in FY2021 (+97.4%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2019.
- Compared with a year earlier, Share-based Compensation has increased for 24 straight quarters, with growth averaging 54.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation ran from 11.7% in Q2 2026 to 135.4% in Q1 2023.
- Per Business Quant data, PCVX's Share-based Compensation in the three quarters before Q2 2026 was $37.96 million (Q1 2026), $36 million (Q4 2025) and $35.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 41.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.24 Mn |
| Mar 31, 2026 | 37.96 Mn |
| Dec 31, 2025 | 36.00 Mn |
| Sep 30, 2025 | 35.31 Mn |
| Jun 30, 2025 | 36.93 Mn |
| Mar 31, 2025 | 30.62 Mn |
| Dec 31, 2024 | 24.37 Mn |
| Sep 30, 2024 | 21.27 Mn |
| Jun 30, 2024 | 21.56 Mn |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 13.35 Mn |
| Sep 30, 2023 | 13.22 Mn |
| Jun 30, 2023 | 12.54 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 7.01 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 5.89 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Sep 30, 2021 | 2.94 Mn |
API Access
Vaxcyte Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();